Michiel A Schreve
Overview
Explore the profile of Michiel A Schreve including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
230
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wegerif E, Nugteren M, van Galen I, Hazenberg C, Schreve M, Akkersdijk G, et al.
J Endovasc Ther
. 2025 Jan;
15266028241312356.
PMID: 39840536
Objective: There is a lack of consensus regarding the optimal antithrombotic therapy (ATT) after popliteal and infrapopliteal (PIP) endovascular therapy (EVT). Currently, dual antiplatelet therapy (DAPT) for 3 months and...
2.
Alozai T, Oud S, Eggen C, Pullens R, Schreve M, Unlu C, et al.
Eur J Vasc Endovasc Surg
. 2025 Jan;
PMID: 39826867
Objective: The aim of this study was to compare anterior accessory saphenous vein (AASV) reflux after standard endovenous laser ablation (EVLA) with flush EVLA (f-EVLA) of the great saphenous vein...
3.
Oud S, Alozai T, Lam Y, Unlu C, Mooij M, Schreve M
J Vasc Surg Venous Lymphat Disord
. 2024 Sep;
13(1):101967.
PMID: 39270843
Objective: The short-term anatomical success rates of mechanochemical ablation using the Clarivein device (Merit Medical) in the treatment of great saphenous vein (GSV) incompetence are high. However, the anatomical success...
4.
Oud S, Alozai T, Schreve M, Mooij M, van Vlijmen C, Unlu C
BMJ Open
. 2024 Aug;
14(8):e087490.
PMID: 39117408
Introduction: Endovenous laser ablation (EVLA) is associated with an excellent outcome in the treatment of great saphenous vein (GSV) incompetence. However, the use of thermal ablation requires tumescent anaesthesia and...
5.
Huizing E, Schreve M, Stuart J, de Vries J, Cagdas U
J Wound Care
. 2024 Feb;
33(2):118-126.
PMID: 38329832
Objective: Current guidelines do not recommend the use of antibiotics to treat clinically uninfected ulcers. However, physicians continue to prescribe antibiotics for clinically uninfected ulcers with the rationale 'better to...
6.
Ucci A, Perini P, Freyrie A, Schreve M, Unlu C, Huizing E, et al.
J Endovasc Ther
. 2023 Nov;
:15266028231210220.
PMID: 38009322
Background: Chronic limb-threatening ischemia (CLTI) is known for its high rates of major amputation and mortality. Conventional revascularization techniques often fail in CLTI patients due to the heavily diseased arteries....
7.
Nugteren M, Hazenberg C, Akkersdijk G, van den Heuvel D, Schreve M, Unlu C
J Endovasc Ther
. 2023 Oct;
:15266028231205421.
PMID: 37853746
Purpose: Vessel calcification is estimated to be present in 30% to 50% of patients with peripheral arterial disease (PAD) and is one of the main challenges in endovascular treatment. The...
8.
Nugteren M, Hazenberg C, Akkersdijk G, Bakker O, Dinkelman M, Fioole B, et al.
PLoS One
. 2023 Jul;
18(7):e0288912.
PMID: 37471351
Introduction: Chronic limb-threatening ischemia (CLTI) is the end stage of peripheral arterial disease (PAD) and is associated with high amputation rates, mortality and disease-related health care costs. In infrapopliteal arterial...
9.
Alozai T, Lam Y, Schreve M, de Smet A, Vahl A, Terlouw-Punt L, et al.
Phlebology
. 2023 Jul;
38(8):532-539.
PMID: 37436708
Objective: This study aimed to compare patient-reported outcomes after technical success (TS) and technical failure (TF) in treating great saphenous vein incompetence (GSV) with ClariVein. Methods: A subanalysis of a...
10.
Huizing E, Schreve M, Kum S, de Borst G, de Vries J, Unlu C
J Endovasc Ther
. 2023 Mar;
31(6):1052-1064.
PMID: 36896877
After percutaneous deep venous arterialization (pDVA), the created arteriovenous circuit needs time to develop. Postprocedural care in patients after pDVA is essential in order to create optimal conditions for maturation...